Health Research Funding in Mexico: The Need for a Long-Term Agenda

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Martínez Martínez, Eduardo ^a   Zaragoza, María Luisa ^a   Solano, Elmer ^a   Figueroa, Brenda ^a   Zúñiga, Patricia ^a   Laclette, Juan P ^a,b  

^a Foro Consultivo Científico y Tecnológico A C   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ACCIDENT; ARTICLE; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORRELATION ANALYSIS; DISABILITY; FUNDING; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HEALTH PROGRAM; HUMAN; INFECTION; INTOXICATION; MEDICAL RESEARCH; MEXICO; NATIONAL COUNCIL ON SCIENCE AND TECHNOLOGY; ORGANIZATION; PARASITOSIS; PUBLIC HEALTH PROBLEM; QUALITY ADJUSTED LIFE YEAR; RESOURCE ALLOCATION; TRAFFIC ACCIDENT; VIOLENCE;

HEALTH SERVICES NEEDS AND DEMAND; HEALTH SERVICES RESEARCH; MEXICO; PLANNING TECHNIQUES;

EID: 84870939179     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051195     Document Type: Article

References (42)

1. Global Forum for Health Research (2002) The 10/90 report on health research, 2001-2002. Geneva, Switzerland: Global Forum for Health Research. 224 p.
2. Alger J, Becerra-Posada F, Kennedy A, Martinelli E, Cuervo LG, (2009) National health research systems in Latin America: a 14-country review. Rev Panam Salud Publica 26: 447-457.
3. Becerra-Posada F, (2009) New possibilities for the development of national systems for the health investigation in America. Salud Publica Mex 51: 86-89.
4. Frenk J, Gomez-Dantes O, Knaul FM, (2009) The democratization of health in Mexico: financial innovations for universal coverage. Bull World Health Organ 87: 542-548.
5. Frenk J, Sepúlveda J, Gómez-Dantés O, Knaul F, (2003) Evidence-based health policy: three generations of reform in Mexico. Lancet 362: 1667-1671.
6. Gakidou E, Lozano R, González-Pier E, Abbott-Klafter J, Barofsky JT, et al. (2006) Assessing the effect of the 2001-06 Mexican health reform: an interim report card. Lancet 368: 1920-1935.
7. King G, Gakidou E, Imai K, Lakin J, Moore RT, et al. (2009) Public policy for the poor? A randomised assessment of the Mexican universal health insurance programme. Lancet 373: 1447-1454.
8. Gonzalez-Block MA, (2009) Leadership, institution building and pay-back of health systems research in Mexico. Health Res Policy Syst 7: 22.
9. Perez-Tamayo R, (2004) La investigacion biomedica en Mexico [Biomedical investigation in Mexico]. Gac Med Mex 140Suppl 1: S37-41.
10. Luna-Morales ME, Collazo-Reyes F, Russell JM, Perez-Angon MA, (2009) Early Patterns of Scientific Production by Mexican Researchers in Mainstream Journals, 1900-1950. J Am Soc Inf Sci 60: 1337-1348.
11. Licea De Arenas J, Castańos-Lomnitz H, Arenas Licea J, (2002) Significant Mexican research in the health sciences: A bibliometric analysis. Scientometrics 53: 39-48.
12. Uribe-Esquivel M, López-Cervantes M, editors (2007) Health Scientific Production in Mexico 1995-2005. Distrito Federal: Academia Nacional de Medicina/Secretaría de Salud/CONACYT. 151 p.
13. Mexico Secretaría de Salud (2001) Programa de Acción: Investigación en Salud. México, D.F.: Secretaría de Salud. 94 p.
14. Frenk J, (1992) Balancing relevance and excellence: organizational responses to link research with decision making. Soc Sci Med 35: 1397-1404.
15. Tugwell P, Sitthi-Amorn C, Hatcher-Roberts J, Neufeld V, Makara P, et al. (2006) Health Research Profile to assess the capacity of low and middle income countries for equity-oriented research. BMC Public Health 6: 151.
16. Gillum LA, Gouveia C, Dorsey ER, Pletcher M, Mathers CD, et al. (2011) NIH Disease Funding Levels and Burden of Disease. PLoS One 6: e16837.
17. Vianna CM, Caetano R, Ortega JA, Facanha LO, Mosegui GB, et al. (2007) Flows of financial resources for health research and development in Brazil, 2000-2002. Bull World Health Organ 85: 124-130.
18. Maceira D, Paraje G, Aramayo F, Masi SD, Sanchez D, (2010) Financiamiento publico de la investigacion en salud en cinco paises de America Latina [Public financing of health research in five Latin American countries]. Rev Panam Salud Publica 27: 442-451.
19. Maceira D (2009) Comparative Study. In: Landriault E, Matlin SA, editors. Monitoring financial flows for health research 2009: Behind the Global Numbers. Geneva: Global Forum for Health Research.
20. Dorsey ER, de Roulet J, Thompson JP, Reminick JI, Thai A, et al. (2010) Funding of US Biomedical Research, 2003-2008. J Am Med Assoc 303: 137-143.
21. Alano JR, Bienvenido P, Almario ES (2000) Tracking country resource flows for health research and development (R & D). Manila: Center for Economic Policy Research.
22. Gross CP, Anderson GF, Powe NR, (1999) The Relation between Funding by the National Institutes of Health and the Burden of Disease. N Engl J Med 340: 1881-1887.
23. Mathers CD, Loncar D, (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Medicine 3: e442.
24. World Health Organization (2008) The global burden of disease: 2004 update. Geneva, Switzerland: World Health Organization.
25. Pérez-Núñez R, Becerra-Posada F, Magaña- Izquierdo M, Demaría L, Idrovo A, et al. (2007) Financial flows for research for health and development in Mexico: An analisis of the National Institutes of Health. In: Burke M, de Francisco A, Matlin SA, editors. Monitoring Financial Flows for Health Research 2007: Behind the Global Numbers. Geneva: Global Forum for Health Research.
26. Abbasi K, (2004) Mexico summit calls for greater commitment to health research. BMJ 329: 1258.
27. Frenk J, González-Pier E, Gómez-Dantés O, Lezana MA, Knaul FM, (2006) Comprehensive reform to improve health system performance in Mexico. Lancet 368: 1524-1534.
28. Singer H, Cooper C, Desai RC, Freeman C, Gish O, et al. (1970) The Sussex Manifesto: Science and Technology to Developing Countries during the Second Development Decade. Brighton: Institute of Development Studies. 1-21 p.
29. Vianna CM, Caetano R, Silva RM, Sampaio M, Rodrigues RR (2009) Brazil: Financing resource flows in health R&D. In: Landriault E, Matlin SA, editors. Monitoring financial flows for health research 2009: Behind the Global Numbers. Geneva: Global Forum for Health Research.
30. Matthews KRW, Calhoun KM, Lo N, Ho V, (2011) The Aging of Biomedical Research in the United States. PLoS One 6: e29738.
31. Aoun S, Pennebaker D, Pascal R, (2004) To what extent is health and medical research funding associated with the burden of disease in Australia? Aust N Z J Public Health 28: 80-86.
32. Lamarre-Cliche M, Castilloux AM, LeLorier J, (2001) Association between the burden of disease and research funding by the Medical Research Council of Canada and the National Institutes of Health. A cross-sectional study. Clin Invest Med 24: 83-89.
33. Maass G, (2004) Funding of Public Research and Development: Trends and Changes. OECD Journal on Budgeting 3: 41-69.
34. Nuyens Y, (2007) Setting priorities for health research: lessons from low- and middle-income countries. Bull World Health Organ 85: 319-321.
35. Rudan I, Chopra M, Kapiriri L, Gibson J, Ann Lansang M, et al. (2008) Setting priorities in global child health research investments: universal challenges and conceptual framework. Croat Med J 49: 307-317.
36. Rudan I, (2012) Global health research priorities: Mobilizing the developing world. Public Health 126: 237-240.
37. Ranson M, Bennett S, (2009) Priority setting and health policy and systems research. Health Res Policy Syst 7: 27.
38. Tomlinson M, Chopra M, Hoosain N, Rudan I, (2011) A review of selected research priority setting processes at national level in low and middle income countries: towards fair and legitimate priority setting. Health Res Policy Syst 9: 19.
39. Alvarez M, Artiles L, Otero J, Cabrera N, (2010) Priority setting in health research in Cuba, 2010. MEDICC review 12: 15-19.
40. Mexico. Secretaría de Salud (2001) Programa de acción: Investigación en Salud. Mexico, D.F.: Secretaría de Salud. 94 p.
41. Torres Guerra S, Gutierrez JP, (2009) [The pharmaceutical market in Mexico: size, value, and concentration]. Rev Panam Salud Publica 26: 46-50.
42. Arundel A, Sawaya D, Valeanu I, (2010) Human Health Biotechnologies to 2015. OECD Journal: General Papers 2009: 113-207.